Inovox Ultra

Flurbiprofen, the active ingredient in Inovox Ultra, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a tablet for oral use. It reduces pain and inflammation in adults with musculoskeletal disorders such as osteoarthritis and rheumatoid arthritis.

GNH USA supplies Inovox Ultra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Flurbiprofen acts on inflammatory pathways to provide analgesia and reduce swelling in several musculoskeletal conditions.

- Pain relief: Alleviates moderate to severe pain associated with acute and chronic musculoskeletal disorders. - Osteoarthritis: Improves joint function and lessens pain in degenerative joint disease. - Rheumatoid arthritis: Decreases inflammatory activity and joint discomfort in autoimmune arthritis. - Inflammation reduction: Lowers systemic inflammatory markers in conditions requiring NSAID therapy.

Flurbiprofen may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Mild skin rash or pruritus. - Elevated liver enzymes without clinical symptoms.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Acute renal failure or worsening of chronic kidney disease. - Severe skin reactions including Stevens‑Johnson syndrome. - Hepatic failure or severe transaminase elevation. - Anaphylaxis or other life‑threatening allergic reactions.

When prescribing Flurbiprofen, clinicians should consider several safety measures.

- Assess gastrointestinal risk: review history of ulcers or bleeding before initiating therapy. - Monitor renal function: adjust use in patients with impaired kidney function. - Avoid in known NSAID hypersensitivity: discontinue if allergic reactions occur. - Use lowest effective dose: limit duration to the shortest period necessary. - Pregnancy and lactation: contraindicated unless benefits clearly outweigh risks. - Store at ambient temperature: keep below 25 °C in the original pack, protect from moisture.

Flurbiprofen can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: heightened risk of ulceration and bleeding.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function. - Diuretics: may impair renal clearance. - Selective serotonin reuptake inhibitors (SSRIs): increased bleeding tendency.